TP53 and cancer: In our preliminary experiments reported here, the SARS-CoV-2 spike-induced inactivation of p53 was correlated to an apparent reduction of expression of DNA damage response protein γ-H2AX after cisplatin exposure and a reduced cell cycle checkpoint response in the cancer cells (Figure 3).